...And the Four Psychological Conditions That Are Lifelong Disorders
John Preston • 2/25/2020
By John Preston - A snapshot of the advancements, setbacks, and future prospects for the world of medication (and why psychotherapy is still just as important as ever).
Daily Blog
How to Mobilize the Client’s Support System
John Preston • 1/10/2018
It’s always cause for celebration when depressed clients nears the finish line of treatment, feeling energized, empowered, and more content with their life. But it’s one thing to get people back on their feet from a depressive episode; it’s another to prevent recurrences down the road.
Daily Blog
Oral Histories of Psychotherapy 1978-2017
Marian Sandmaier, Bessel van der Kolk, John Gottman, Dan Siegel, John Preston, Ken Hardy, Mary Jo Barrett, Salvador Minuchin • 1/1/2017
A group of innovators and leaders look back over different realms of therapeutic practice and offer their view of the eureka moments, the mistakes and misdirections, and the inevitable trial-and-error processes that have shaped the evolution of different specialty areas within the field.
- Trauma: Retreats and Advances BESSEL VAN DER KOLK
- Couples: In Search of a Safe Haven JOHN GOTTMAN
- Systems Therapy: The Art of Creating Uncertainty SALVADOR MINUCHIN
- Family Violence: Out of the Shadows MARY JO BARRETT
- Psychopharmacology: The Jury Is Still Out JOHN PRESTON
- Race Matters: How Far Have We Come? KENNETH HARDY
- Neuroscience and Therapy: The Craft of Rewiring the Brain DANIEL SIEGEL
Magazine Article
Helping Clients Recognize their Treatment Options
John Preston • 8/13/2014
When it comes to treating depression, neuropsychologist John Preston, author of Clinical Psychopharmacology Made Ridiculously Simple, says that psychoactive medication is only one alternative and often not the most effective. In addition to his integrative approach—which includes exercise, combating social withdrawal, family involvement, and possibly meds—he’s always on the lookout for toxic relationship issues in the client’s life.
Daily Blog
Have They Lived up to Their Promise?
John Preston • 7/11/2014
After wading through the controversies and contradictions in the research literature on SSRIs, a critic of Big Pharma explains why he thinks these drugs may have gotten a bad rap.
Magazine Article
It’s More Complicated Than That: Probing the complexities of the antidepressants debate
John Preston • 1/1/2012
The recent spate of negative research findings and unfavorable media coverage of antidepressant drugs have obscured some important clinical issues.
Magazine Article